Actively Recruiting
Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes
Led by Tor Biering-Sørensen · Updated on 2025-09-12
1428
Participants Needed
1
Research Sites
182 weeks
Total Duration
On this page
Sponsors
T
Tor Biering-Sørensen
Lead Sponsor
B
Boston Scientific Corporation
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the study is to assess the impact of HeartLogic-guided management on clinical outcomes among patients implanted with an eligible cardiac device.
CONDITIONS
Official Title
Danish Pragmatic Randomized Trial to Evaluate the Effect of HeartLogic-Guided Management on Heart Failure Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Implanted with a CRT-D or ICD device that has HeartLogic capability and ability to change HeartLogic enablement per randomization
- Age 18 years or older
- Compliant with remote monitoring and not listed in the LATITUDE17 remote monitoring system as "not monitored"
You will not qualify if you...
- There are no specific exclusion criteria for the trial.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte
Hellerup, Capital Region, Denmark, 2900
Actively Recruiting
Research Team
N
Niklas Dyrby Johansen, MD
CONTACT
M
Marie Terese Barlebo Madsen, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here